Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business
NEW YORK – Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE: ASH) (“Ashland Nutraceuticals” or the “Business”). Ashland Nutraceuticals is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Business … Continue reading Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business